Patents by Inventor Brian Gliniak

Brian Gliniak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYPEPTIDES AND ANTIBODIES
    Publication number: 20130101589
    Abstract: Polypeptides are provided. Antibodies or antigen binding domains are provided which bind such polypeptides. Also provided are methods of obtaining an antibody that binds tumor necrosis factor (TNF)-related apoptosis-inducing ligand (“TRAIL”) Receptor-2 (TR-2) comprising administering at least one of such polypeptides to an animal and obtaining an antibody that binds TR-2 from the animal. Antibodies reactive with TR-2 are provided. Also provided are cells producing antibodies reactive with TR-2, pharmaceutical compositions comprising antibodies reactive with TR-2, methods using antibodies reactive with TR-2, and kits comprising antibodies reactive with TR-2. Also provided are methods of decreasing or preventing binding of an antibody to TR-2 by administering such a polypeptide.
    Type: Application
    Filed: September 7, 2012
    Publication date: April 25, 2013
    Inventors: Brian Gliniak, Xiao-Dong Yang, Sharon Wong-Madden, Ian Foltz, Xiao Feng, Alison Fitch, Stephen Foster, Randal R. Ketchem
  • Polypeptides and Antibodies
    Publication number: 20090226438
    Abstract: Polypeptides are provided. Antibodies or antigen binding domains are provided which bind such polypeptides. Also provided are methods of obtaining an antibody that binds tumor necrosis factor (TNF)-related apoptosis-inducing ligand (“TRAIL”) Receptor-2 (TR-2) comprising administering at least one of such polypeptides to an animal and obtaining an antibody that binds TR-2 from the animal. Antibodies reactive with TR-2 are provided. Also provided are cells producing antibodies reactive with TR-2, pharmaceutical compositions comprising antibodies reactive with TR-2, methods using antibodies reactive with TR-2, and kits comprising antibodies reactive with TR-2. Also provided are methods of decreasing or preventing binding of an antibody to TR-2 by administering such a polypeptide.
    Type: Application
    Filed: April 2, 2009
    Publication date: September 10, 2009
    Inventors: Brian Gliniak, Xiao-Dong Yang, Sharon Wong-Madden, Ian Foltz, Xiao Feng, Alison Fitch, Stephen Foster, Randal R. Ketchem
  • TRAIL receptor-2 polypeptides and antibodies
    Patent number: 7521048
    Abstract: Polypeptides are provided. Antibodies or antigen binding domains are provided which bind such polypeptides. Also provided are methods of obtaining an antibody that binds tumor necrosis factor (TNF)-related apoptosis-inducing ligand (“TRAIL”) Receptor-2 (TR-2) comprising administering at least one of such polypeptides to an animal and obtaining an antibody that binds TR-2 from the animal. Antibodies reactive with TR-2 are provided. Also provided are cells producing antibodies reactive with TR-2, pharmaceutical compositions comprising antibodies reactive with TR-2, methods using antibodies reactive with TR-2, and kits comprising antibodies reactive with TR-2. Also provided are methods of decreasing or preventing binding of an antibody to TR-2 by administering such a polypeptide.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: April 21, 2009
    Assignee: Amgen Inc.
    Inventors: Brian Gliniak, Xiao-Dong Yang, Sharon Wong-Madden, Ian Foltz, Xiao Feng, Alison Fitch, Stephen Foster, Randal R. Ketchem
  • Polypeptides and antibodies
    Publication number: 20070179086
    Abstract: Polypeptides are provided. Antibodies or antigen binding domains are provided which bind such polypeptides. Also provided are methods of obtaining an antibody that binds tumor necrosis factor (TNF)-related apoptosis-inducing ligand (“TRAIL”) Receptor-2 (TR-2) comprising administering at least one of such polypeptides to an animal and obtaining an antibody that binds TR-2 from the animal. Antibodies reactive with TR-2 are provided. Also provided are cells producing antibodies reactive with TR-2, pharmaceutical compositions comprising antibodies reactive with TR-2, methods using antibodies reactive with TR-2, and kits comprising antibodies reactive with TR-2. Also provided are methods of decreasing or preventing binding of an antibody to TR-2 by administering such a polypeptide.
    Type: Application
    Filed: August 28, 2006
    Publication date: August 2, 2007
    Inventors: Brian Gliniak, Xiao-Dong Yang, Sharon Wong-Madden, Ian Foltz, Xiao Feng, Alison Fitch, Stephen Foster, Randal Ketchem